Single and Multiple Dose Safety, Tolerability and Pharmacokinetics of the Selective M1 Receptor Partial Agonist HTL0018318 in Healthy Volunteers

被引：0

作者：

Nathan, Pradeep ^{[1
]}

Liptrot, Jan ^{[1
]}

Bakker, Charlotte ^{[1
]}

'tHart, Ellen ^{[1
]}

Klaassen, Erica ^{[1
]}

Prins, Samantha ^{[1
]}

van der Doef, Thalia ^{[1
]}

Walker, Mike ^{[1
]}

Brown, Giles ^{[1
]}

Brown, Alastair ^{[1
]}

Congreve, Miles ^{[1
]}

Weir, Malcolm ^{[1
]}

Marshall, Fiona ^{[1
]}

Cross, David ^{[1
]}

Groeneveld, Geert Jan ^{[1
]}

Tasker, Tim ^{[1
]}

机构：

[1] Sosei Heptares, Cambridge, England

来源：

NEUROPSYCHOPHARMACOLOGY | 2018年 / 43卷

关键词：

M1 and M4 Muscarinic Receptors; Phase; 1; Safety; Pharmacokinetics; Dementia;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

W51

引用

页码：S408 / S409

页数：2

共 50 条

[21] ASCENDING MULTIPLE-DOSE STUDY WITH PONESIMOD, A SELECTIVE SIP1 RECEPTOR AGONIST: TOLERABILITY, SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS
Brossard, P.
Maatouk, H.
Halabi, A.
Dingemanse, J.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S93 - S93
[22] Safety, tolerability, and pharmacokinetics of single and multiple doses of KNS-760704 in healthy volunteers
Graham, Cheryl F.
Mather, James L.
Ingersoll, Evan W.
Kramer, William G.
Hebrank, Gregory T.
Bozik, Michael E.
JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (09): : 1107 - 1107
[23] Safety, tolerability, and pharmacokinetics of sumatriptan suppositories following single and multiple doses in healthy volunteers
Kunka, RL
Hussey, EK
Shaw, S
Warner, P
Aubert, B
Richard, I
Fowler, PA
Pakes, GE
CEPHALALGIA, 1997, 17 (04) : 532 - 540
[24] Pharmacokinetics, pharmacodynamics, safety and tolerability of cilofexor, a novel nonsteroidal Farnesoid X receptor agonist, in healthy volunteers
Younis, Islam R. R.
Kirby, Brian J. J.
Billin, Andrew N. N.
Xiao, Deqing
Song, Qinghua
Watkins, Timothy R. R.
Othman, Ahmed A. A.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (03): : 536 - 547
[25] Phase 1 Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers
Merica, VarshaIyer Elizabeth
Ronseaux, Sebastien
Gamache, Tressa
Mulrow, Nancy J.
Belcijan, Anja
Callaghan, Michael U.
BLOOD, 2021, 138
[26] Safety, Tolerability, and Pharmacokinetics of Intravenous Oseltamivir: Single- and Multiple-Dose Phase I Studies with Healthy Volunteers
Brennan, Barbara J.
Davies, Brian
Cirrincione-Dall, Georgina
Morcos, Peter N.
Beryozkina, Anna
Chappey, Colombe
Baldo, Pau Aceves
Lennon-Chrimes, Sian
Rayner, Craig R.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (09) : 4729 - 4737
[27] Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers
Barbour, April M.
Sarov-Blat, Lea
Cai, Gengqian
Fossler, Michael J.
Sprecher, Dennis L.
Graggaber, Johann
McGeoch, Adam T.
Maison, Jo
Cheriyan, Joseph
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (01) : 99 - 106
[28] Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers
Yingxin Li
Yang Li
Li Li
Wei Xue
Kong Xin
Titi Wang
Aixin Shi
Clinical Drug Investigation, 2023, 43 (6) : 413 - 420
[29] Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers
Li, Yingxin
Li, Yang
Li, Li
Xue, Wei
Xin, Kong
Wang, Titi
Shi, Aixin
CLINICAL DRUG INVESTIGATION, 2023, 43 (06) : 413 - 420
[30] Pharmacokinetics, safety, and tolerability of single intravenous infusions of an adenosine agonist, AMP 579, in healthy male volunteers
Zannikos, PN
Baybutt, RI
Boutouyrie, BX
Shah, B
Hunt, TL
Jensen, BK
JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (10): : 1044 - 1052

← 1 2 3 4 5 →